Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease-Reference-Cited by-同舟云学术

Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease

Published:2019-04-01 Issue:4 Volume:76 Page:492
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Chohan Muhammad O.¹²,Marchiò Serena¹²³⁴,Morrison Leslie A.⁵,Sidman Richard L.⁶,Cavenee Webster K.⁷,Dejana Elisabetta⁸⁹¹⁰¹¹,Yonas Howard²,Pasqualini Renata¹²¹³,Arap Wadih¹²¹⁴

Affiliation:

1. The University of New Mexico Comprehensive Cancer Center, Albuquerque

2. Department of Neurosurgery, University of New Mexico School of Medicine, Albuquerque

3. Department of Oncology, University of Torino School of Medicine, Candiolo, Torino, Italy

4. Candiolo Cancer Institute-Fondazione del Piemonte per l’Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, Candiolo, Torino, Italy

5. Department of Neurology, University of New Mexico School of Medicine, Albuquerque

6. Department of Neurology, Harvard Medical School, Boston, Massachusetts

7. Ludwig Institute for Cancer Research, University of California, San Diego

8. Fondazione Italiana per la Ricerca sul Cancro Institute of Molecular Oncology Fondazione, Milan, Italy

9. Mario Negri Institute for Pharmacological Research, Milan, Italy

10. Department of Biosciences, School of Sciences and Department of Oncology, School of Medicine, Milano University, Milan, Italy

11. Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden

12. Rutgers Cancer Institute of New Jersey at University Hospital, Newark

13. Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark

14. Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Link

http:///jamaneurology/article-pdf/76/4/492/17436126/jamaneurology_chohan_2018_rv_180010.pdf

Reference80 articles.

1. Natural history and imaging prevalence of cavernous malformations in children and young adults.;Al-Holou;J Neurosurg Pediatr,2012

2. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.;Wong;Neurosurgery,2000

3. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas.;Pozzati;Neurosurgery,1996

4. Prospective hemorrhage rates of cerebral cavernous malformations in children and adolescents based on MRI appearance.;Nikoubashman;AJNR Am J Neuroradiol,2015

5. Hemorrhage from cavernous malformations of the brain: definition and reporting standards.;Al-Shahi Salman;Stroke,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLNRD1 is a CCM complex component and regulates endothelial barrier integrity;Journal of Cell Biology;2024-07-16

2. Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives;2024-07-01

3. Identifying potential (re)hemorrhage among sporadic cerebral cavernous malformations using machine learning;Scientific Reports;2024-05-14

4. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome;Stroke;2024-01

5. Intramedullary Spinal Cord Cavernous Malformations: Clinical Features and Surgical Management;Endovascular and Neurovascular Surgery for Spinal Vascular Malformations;2024